• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      Pharma Businesses

      Pharma businesses that are rewired will win in the digital era

      13th July 2023

      Featured Chronicle

      ESG

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      The Pros and Cons of Cloud Computing

      The Pros and Cons of Cloud Computing

      13th July 2023
      Let's Read

      Press Room

      Healthcare AI Innovation

      Healthcare AI innovation: a new era of patientcare

      13th July 2023
      Let's Understand

      Article

      Electric Vehicle Thermal Management System (EVTMS) Market

      19th May 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Pharmaceutical Icon

Pendred Syndrome (PS) Market – Trends Forecast Till 2030

Pendred Syndrome (PS) Market by Treatment (Cochlear Implant, Hearing Aids, and Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

  • Published Date : August 2023
  • Base Year Estimate : 2022
  • Report ID : D-PH-PSM-1534
  • Format :
  • Number of Pages : 580
  • Domain : Pharmaceutical
  1. Pharmaceutical
  2. Pendred Syndrome (PS) Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Pendred Syndrome (PS) market size was estimated at USD 2.82 billion in 2023 and is projected to reach USD 3.83 billion in 2030 at a CAGR of 4.5% during the forecast period 2023-2030.

Pendred syndrome, often abbreviated to PS, is a rare genetic disorder characterized by a combination of sensorineural hearing loss and thyroid dysfunction. It is named after British physician Vaughan Pendred, who first described the syndrome in the early 20th century. Pendred syndrome is caused by mutations in the SLC26A4 gene, also known as the pendrin gene. This gene codes for a protein called pendrin, which plays a critical role in the transport of ions (charged particles) through the cell membranes of the cochlea and thyroid gland.

The global pendred syndrome market is growing steadily due to the prevalence of pendred syndrome and rising healthcare costs. Growing R&D activity is significantly driving the global flexion syndrome market. Strategic initiatives by major market players are one of the reasons for the rapid growth of the market. Market participants are expanding their product offerings to gain a competitive advantage.

On the other hand, high cost of the product may hamper the market growth to some extent.

The COVID-19 pandemic potentially disrupted the Pendred Syndrome (PS) market by delaying diagnoses, access to treatment and research. Healthcare disruptions, supply chain challenges and changing priorities may have hindered patient care and research. Telehealth adoption has increased, but may not completely replace the need for in-person care. The wider financial impact of the pandemic may also have affected funding for research and patient support networks, affecting progress in understanding and treating Pendred syndrome.

Delvens Industry Expert's Standpoint

The pandemic had a considerable impact on businesses globally, with nations like India and China bearing the brunt of the virus's outbreak. The Rising incidence of Pendred syndrome, a genetic disorder characterized by hearing loss and thyroid dysfunction, is a major driver of the market. Growing awareness and improved diagnostic methods are helping to identify and diagnose more cases, increasing the demand for treatment and care. Advances in genetic testing techniques and technologies have enabled a more accurate and efficient diagnosis of Pendred syndrome. Genetic testing plays a critical role in identifying genetic mutations associated with Pendred syndrome, facilitating early detection and individualized treatment strategies. These factors have led to the expansion of the market and increased demand for Pendred Syndrome (PS) solutions.

Market Portfolio

Key Findings

  • The Treatment segment is further fragmented into Cochlear Implant, Hearing Aids, and Radioactive Iodine. The Cochlear Implant segment is expected to account for a larger market size during the forecast period. Cochlear implants are electronic devices that are surgically implanted into the inner ear to provide a sense of sound for individuals with severe to profound hearing loss. In Pendred Syndrome, where sensorineural hearing loss is a common feature, cochlear implants can be considered for those who do not significantly benefit from conventional hearing aids.
  • The diagnosis segment is further bifurcated into Genetic Testing, Perchlorate Washout Test, and Others. The Genetic Testing is the largest market during the forecast period. Genetic testing is a crucial tool in diagnosing Pendred Syndrome. This involves analyzing the DNA of an individual to identify mutations in the SLC26A4 gene, which is associated with the syndrome. Genetic testing can confirm the presence of mutations that lead to abnormal functioning of the pendrin protein. Identifying these mutations can help establish a definitive diagnosis of Pendred Syndrome.
  • The End- Users segment is further bifurcated into Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others. The Hospitals is the largest market during the forecast period. Hospital-based otolaryngologists (ear, nose, and throat specialists) can assess the severity of hearing loss, conduct inner ear imaging, and provide guidance on treatment options, including hearing aids and cochlear implants. Hospitals also facilitate communication and collaboration between different medical specialists involved in the care of individuals with Pendred Syndrome.
     
  • The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period owing to the rising healthcare costs, increased R & D, and trending technological advancements.

Regional Analysis

North America to Dominate the Market

  • North America is estimated to account for the largest market share during the forecast period due to rising healthcare costs, increased R & D, and trending technological advancements.
     
  • Moreover, Moreover, growing focus of major key players on further R&D will further propel the market’s growth rate in this region.

 

Competitive Landscape

  • Nobel pharma Co.,Ltd
  • Sensorion
  • Advanced Bionics AG
  • MED-EL Medical Electronics
  • Cochlear Ltd
  • Sonova
  • GAES
  • Demant A/S
  • Nurotron Biotechnology Co. Ltd
  • GN Store Nord A/S
  • Amplifon
  • Audina Hearing Instruments, Inc.
  • ElkonPvt Ltd
  • Rion Co. Ltd
  • Starkey